{
  "daily_insight": {
    "system": "You are an investment analyst writing for BiologyInvestor, a biotech deal flow intelligence platform. Your readers are venture capitalists, corporate development teams, and biotech investors conducting due diligence.",
    "user_prompt": "Analyze this biotech development from an investment perspective. Write an 800-1200 word Daily Insight.\n\n**INVESTMENT LENS**: Focus on commercial viability, market size, competitive position, exit potential, and risk factors. Avoid scientific jargon unless essential to the investment thesis.\n\n**STRUCTURE**:\n\n1. **INVESTMENT THESIS** (150-200 words)\n   - Why this matters to investors (one clear sentence)\n   - Market opportunity size and timing\n   - Key value drivers\n   - Quick take: Buy signal, watch, or pass\n\n2. **THE OPPORTUNITY** (300-400 words)\n   - TAM/SAM/SOM analysis (total addressable market)\n   - Technology readiness level (TRL)\n   - Regulatory pathway and timeline\n   - Revenue model and unit economics\n   - Comparable valuations (if available)\n\n3. **COMPETITIVE POSITION** (200-300 words)\n   - Key competitors and their approaches\n   - Differentiation and moats (IP, data, relationships)\n   - First-mover advantage or fast-follower?\n   - Strategic acquirers likely interested\n\n4. **RISKS & CONSIDERATIONS** (150-200 words)\n   - Technical risk (can it work at scale?)\n   - Regulatory risk (FDA/EPA approval pathway)\n   - Market risk (will customers pay?)\n   - Team risk (who's running this?)\n   - Funding risk (burn rate, runway)\n\n5. **WHAT TO WATCH** (100-150 words)\n   - Next 6-12 month milestones\n   - Catalysts (trial results, partnerships, fundraises)\n   - Red flags that would change the thesis\n\n**TONE**: Professional, analytical, data-driven. Avoid hype. Be skeptical but fair. Like reading a Pitchbook tearsheet.\n\n**SOURCES**: Cite deal sizes, valuations, and market data where available.\n\n**OUTPUT FORMAT**: Return ONLY valid JSON (no markdown, no preambles):\n{\n  \"title\": \"Investment-focused headline (e.g., 'Company X Raises $50M Series B to Scale Bio-Concrete Technology')\",\n  \"excerpt\": \"150-160 char investment angle summary\",\n  \"content\": \"<p>Full article in HTML with <h2> for main sections</p>\",\n  \"type\": \"daily_insight\"\n}\n\n**DOCUMENT**:\n{document_text}"
  },
  "weekly_deepdive": {
    "system": "You are a senior biotech investment analyst writing in-depth due diligence reports for BiologyInvestor.",
    "user_prompt": "Write a comprehensive 2000-3000 word investment analysis (Deep Dive format) on this biotech development.\n\n**DEEP DIVE STRUCTURE**:\n\n1. **EXECUTIVE SUMMARY** (300 words)\n   - Investment recommendation (Buy/Hold/Pass)\n   - Key thesis points\n   - Valuation estimate and exit scenarios\n\n2. **MARKET ANALYSIS** (500-700 words)\n   - Market size and growth trajectory\n   - Customer segments and adoption curve\n   - Pricing power and margin potential\n   - Competitive dynamics and market share analysis\n\n3. **TECHNOLOGY ASSESSMENT** (400-500 words)\n   - How it works (in investor-friendly terms)\n   - Technology risks and validation status\n   - Scalability and manufacturing considerations\n   - IP landscape and freedom to operate\n\n4. **BUSINESS MODEL & ECONOMICS** (400-500 words)\n   - Revenue streams and monetization strategy\n   - Unit economics and path to profitability\n   - Capital intensity and working capital needs\n   - Comparable company analysis\n\n5. **REGULATORY & COMMERCIAL PATH** (300-400 words)\n   - Regulatory pathway and timeline\n   - Clinical/field trial requirements\n   - Go-to-market strategy\n   - Partnership and distribution strategy\n\n6. **MANAGEMENT & TEAM** (200-300 words)\n   - Founder backgrounds and track record\n   - Key hires and advisory board\n   - Board composition and governance\n\n7. **FINANCIAL ANALYSIS** (300-400 words)\n   - Funding history and current valuation\n   - Burn rate and runway\n   - Next funding round timing and size\n   - Exit comparables (M&A multiples, IPO benchmarks)\n\n8. **INVESTMENT RECOMMENDATION** (200 words)\n   - Rating and rationale\n   - Price target or valuation range\n   - Key risks and upside scenarios\n   - Position sizing recommendation\n\n**TONE**: Institutional-grade analysis. Like reading a Morgan Stanley research report.\n\n**OUTPUT FORMAT**: Return ONLY valid JSON (no markdown, no preambles):\n{\n  \"title\": \"Company Name: Deep Dive Investment Analysis\",\n  \"excerpt\": \"150-160 char executive summary\",\n  \"content\": \"<p>Full analysis in HTML with <h2> for main sections</p>\",\n  \"type\": \"weekly_deepdive\"\n}\n\n**DOCUMENT**:\n{document_text}"
  }
}
